C. diff. Spores and More

"Metronidazole For the Treatment of C. difficile Infections: On the Way Out?" - Presented by: Wiep Klaas Smits, Ph. D., Department of Medical Microbiology Leiden University Medical Center.

Inaugural Dale Gerding Lifetime Achievement Award - Presented by Sahil Khanna, MBBS MS, Professor of Medicine in the Division of Gastroenterology and Hepatology,, Mayo Clinic to Dale Gerding, MD, FACP, FIDSA.

“Introducing a New Disinfection Technology Against C. diff.

We welcome our guest, Madeline King, PharmD, BCIDP Assistant Professor of Clinical Pharmacy, Infectious Diseases, Department of Pharmacy Practice & Pharmacy Administration. Dr. King joins us to discuss the updated Clostridioides difficile (C.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

"Caring For a Loved One Diagnosed With a CDI" --- “Is this C.diff.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Join us with our guests from GoodNature, a Seres Therapeutics program; April Garcia, Site Manager of GoodNature Irvine California, and two GoodNature donors who will share their experiences.

Join Us With our guest, Sahil Khanna, M.B.B.S., M.S. as we discuss the exciting times of Microbiome Restoration For C. difficile infections and how we are almost there! Dr.

Join us with our guest; Ken Blount PhD, CSO Rebiotix Inc, a Ferring Company and VP Microbiome Research Ferring - as Dr. Blount introduces the gut microbiome.

Approximately 10% of all U.S. patients report having an allergic reaction to a penicillin class antibiotic in their past. 10% of the population reports a penicillin allergy but <1% of the whole population is truly allergic.

Join Nancy C. Caralla and Kevin Hersh as we discuss the chapters and passion behind the newly published book, "Managing a C. difficile Infection: For Patients, Families, and Caregivers."

Niranjan "Tex" Kissoon , MD Mark Ansermino, MD and Matthew Wiens, MD join us to discuss the multi-levels of Sepsis,. and educate us on the What, How, and Global Burden of Sepsis.

Wendy Benson is partner and COO at 2x2 Health: Private Health Concierge, culminating from her extensive experience as a leading healthcare executive and occupational therapist.

Join Doctors Caterina Oneto, and Paul Feuerstadt, as they discuss the Management of C. difficile Infections. The new guidelines released by IDSA and SHEA this June along with the new treatments on the horizon will also be a topic of conversation.

Join Our Guests: Linda Davis, RN, Charlotte Johnson, & Renata Johnson as they discuss key points on caregiving, a journey of caring for a loved one with a C. diff.

With microbiome therapeutics on the forefront, it will be an educational discussion with our guests: Jason Goldsmith, Donor Medical & Analytical Sciences, Elisha Ott, Director, Donor Operations, and Jennie Starr, Associate Director, Donor Recruitment.

Join our guests: Neil Clark, Chief Executive Officer, Destiny Pharma PLC and Dale Gerding, MD, FACP, FIDSA, FSHEA with our Guest Host: Kevin Hersh.

Join our guests, Missy Travis, RN, and Priya Balachandran, Ph. D.

Join us with our guest, Ron Roman, RN, CEO Safety Net as we discuss creating a safe environment, maintaining a safe environment in both healthcare and home.

This is a Special Presentation: Join us with our three brave guests as they take a step forward to share their C. difficile infection journey and deliver a personal message with our global listeners. "It's NOT Just Diarrhea."

Join us with our guest, Professor Simon Cutting, Ph. D., as we discuss the genetic control of spore formation in Bacillus subtilis, and the research behind the scenes defining Clostridioides difficile in health and environment.

Join us with our guest, Ron Roman, RN, CEO Safety Net as we discuss creating a safe environment, maintaining a safe environment in both healthcare and home.

Join us with three C. diff. Survivors - Christine, Alba, and Renata, as they share their personal message with you. We are grateful for their time and for sharing their C. diff. infection experiences with us.

Join Our Guests Camilla Graham MD "Ri-CoDIFy: Ridinilazole’s Phase 3 Trial for the Treatment of C. difficile and Reduction of Recurrence." . Dr.Camilla S.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers.

A Symposium specifically developed for Patients Diagnosed With a C. diff. Infection, Being Treated For a Clostridioides diffiicile infection, Recovering From a Clostridioides difficile Infection and Recurrences with Family Members and Caregivers.

Welcome to the second episode of a special four (4) part series: A Symposium Created For Patients Diagnosed With a C. diff.

The Patient & Family C. diff.

Dr. Tamas Haidegger, Ph. D., Associate Professor Obuda University, and Co-founder: HandInscan will be discussing the importance of not only hand-washing but how Hand Hygiene is the top priority in social safety.

Join us with our guest Dr. Robert Carman, Ph. D., Director of Microbiology at TECHLAB, Inc. Dr. Carman's research focuses on Clostridioides difficile (C. diff., C. difficile, CDI). Dr.

Welcome to Episode 6 of 6; of the 8th Annual International C. diff. Post-Conference Special series Sponsored by Summit Therapeutics.

Welcome to Episode 5 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics.

Welcome to Episode 4 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics.

Welcome to Episode 3 of 6; of the 8th Annual Int'l C. diff. Post-Conference special series Sponsored by Summit Therapeutics.

Welcome to Episode 2 of 6; of the 8th Annual Int'l C. diff. Post-Conference Special series Sponsored by Summit Therapeutics.

Welcome to Episode 1 of 6; 8th Annual Int'l C. diff. Post-Conference Special Series Sponsored by Summit Therapeutics.

Join us with our guests: Layla and Emma, members of a group of students, also known as the Golden Pandas, an FLL Robotics Team from Westfield, IN who has developed a special interest in helping to fight C. diff. infections.

Join our guests Andrew Rushworth and Mike Short as they discuss essential tools in an infection control program.

Dr. David M. Lyerly, Ph. D., Chief Science Officer, TechLab, Inc. will be joining us to discuss "C. difficile Infections (CDI) and Secondary Bacterial Pneumonia." Dr.

Join us with our guest James Boone, M.S., as we discuss Inflammatory Bowel Disease patients who are highly susceptible to C. difficile infections. The two diseases have similar symptoms, but very different treatments.

Join our guests, Paul Feuerstadt, MD, FACG, and Mena Boules, MD join us to discuss Esophagitis and Chronic Idiopathic Constipation.

Join us with our two guests: Edmond A. Hooker, MD, DrPH, and Bruce Rippe, CEO Trinity Guardion as we discuss the "Three Cleaning and Disinfection Mistakes that Put Patients At Risk" Both Dr.

Join us with our guest, Barbara DeBaun, RN, MSN, CIC. Barbara DeBaun has over 40 years of experience in the field of infection prevention and quality improvement.

Join us with our guest, Dr. Anthony Gerlach, PharmD, as we discuss the role of the pharmacist focusing on clinical pharmacist or rounding pharmacist. He will also discuss how clinical pharmacists are involved in the treatment and prevention of C. diff.

Join us with Guest; Mrs. Courtney Jones as we discuss we can cover the microbiome & C.

Our guests from Seres Therapeutics shared the latest news on SER-109 and positive topline results from the pivotal Phase 3 ECOSPOR III study evaluating its investigational oral microbiome therapeutic SER-109 for recurrent C. difficile infection (CDI).

Join us with our guest: Candida Fratazzi, MD, Consulting Medical Director at Vedanta Biosciences, focused on pioneering rational design of drugs, made of defined consortia of bacteria, to Modulate the Human Microbiome. Dr.

Join us with Guest; Doe Kley, RN, CIC, MPH,T-CHEST Senior Infection Preventionist with Clorox Professional Products Co. Ms.

Join us with our Guest; Dale N. Gerding, MD, MACP, FIDSA, FSHEA. Dr. Gerding is a Research Physician at the Edward Hines Jr. VA Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois (retired).

Our two guests, Teena Chopra, MD, MPH and Glenn Tillitson, PhD,FIDSA, will be discussing how C. diff.

Join us in Part II of this educational discussion with guests Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC and Denise Graham discussing a safe, continuous, green, and real-time technology.

Join us with guests Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC and Denise Graham in discussing a safe, continuous, green, and real-time technology.

Join us with our two guests: Dr Yannick Pletan, Independent Director Clinical development specialist,Doctor of medicine, and Georges Gaudriault, Scientific Director, PhD in molecular pharmacology. Both Dr.

PART II The 2019–20 coronavirus pandemic is a pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, Hubei, China in December 2019.

The 2019–20 coronavirus pandemic is a pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, Hubei, China in December 2019.

Join us with guests: Leigh Veasey, Sales Director - North America and Wendy Brady, Marketing Director - North America of Intellego Technologies.

The 2019–20 coronavirus pandemic is a pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, Hubei, China in December 2019.

Join us with our guest: Mrs. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases. Mrs.

Join us with our Host, Nancy Caralla and our special Guest Host, Kevin Hersh, International Health Coach who will discuss ways to move forward past a long-term illness, and a long-term negative mind-set.

Join us with our special guest, Sabine Hazan, MD, a gastroenterology specialist in Ventura, CA and has been practicing for 22 years. Dr.

Join us with our guest: Jennifer W., a fellow-C. diff. Survivor, as we discuss positive changes, both big and small, that may help improve the way that you feel during any wellness-draining illness.

Join Your Host, Nancy Caralla, with Guest Host Kevin Hersh as they discuss proven ways to prevent the FLU virus and more.

This special episode with Host Nancy Caralla and Guest Host Kevin Hersh turn up the volume with C. diff. Survivors Jennifer W. and Robin S. as they share their journey through a C. diff. infection.

Join Us with guest: Karl Kappeler, MS, RPh, FASHP Director, Medical Affairs of Azurity Pharmaceuticals. and will be discussing C. difficile infections, C. diff.

Join Our Guests: Kerrie Davies, Principal Clinical Scientist, and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and the University of Leeds, and Dr.

Join us with guest, L. Clifford McDonald, MD. Dr. McDonald, MD graduated from Northwestern University Medical School. He completed a medical microbiology fellowship at Duke University and is a former member of CDC’s Epidemic Intelligence Service. Dr.

Join us with our guests: Caitlin Stowe is a master’s prepared infection preventionist currently employed with PDI as the Clinical Affairs Research Manager and Megha Patel is a Senior Product Manager with PDI, focused on new product development.

Join us with Guest: Henry R Herrera Jr., MD, a Gastroenterology specialist. Dr. Herrera will be discussing the complications of a C. diff. infection and Inflammatory Bowel Disease (IBD).

Join us with our guest: Maureen Spencer, RN, M.Ed., CIC joining us to discuss an array of important topics: 1. Overuse and inappropriate prescribing of antibiotics worldwide is leading to the global healthcare issue of antibiotic resistance. 2.

Join us with guest Sahil Khanna, MD, M.B.B.S Dr. Khanna, MD, MBBS, is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. Dr. Khanna will be discussing Antibiotics treating C.

Join us with guests Ron Romano, RN and Jenn Robke, RN as they discuss the main question in today's episode is not what products are being utilized to address germs and bacteria. Listen in to learn more

Join our guests Beatrix M. Babcock, MS HSA, LPN and Michael Kupneski is the R and ;D Section Head for Procter and Gamble Professional.

Guest Kevin Hersh, an International Health Coach, joins us to discuss the tools that are able to create positive effects while coping with the stressors of returning back to school, and maintaining the balance in life.

Join us with guest Bernat Olle, MS, PhD as we discuss Defined Bacterial Consortia for Prevention of a C. difficile infection (CDI) Recurrence.

Professor Simon Cutting joins us and shares his thoughts and scientific research focused on C.difficile prevention, treatments, and probiotics. The C.diff. infection concept of 20 years ago is not what it is today.

Join us with our guest: Mrs. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases. Mrs.

The Centers for Medicare and Medicaid Services (CMS) regulations, revised in the past few years, will improve infection control in long term care facilities and must be fully implemented by November 2019.

Join us with guest Dr. David Lyerly, PhD - Co-Founder, CSO of TechLab. Dr. Lyerly will be discussing C.diff. (C.difficile) in the IBD Patient ~ the research,clinical assays for enteric and autoimmune diseases. Dr.

Join your host Nancy C. Caralla with guest host Kevin Hersh as we discuss Positive Healthy Habits that helped you and your family during and after a C.diff. infection and all other wellness draining illnesses.

Join us with our guests Elizabeth A.

Join us as our guests Kerrie Davies, Principal Clinical Scientist and Visiting Research Fellow, Leeds Teaching Hospitals NHS Trust and University of Leeds and Professor Mark H.

Join us with our guests Sue Barnes, RN, BSN, CIC, FAPIC, Wesley LaPorte -- as they discuss the risks of contamination of cell phones and tablets. Tune in to learn more about the type of germs that can be transferred from mobile devices to individuals.

Reducing Surgical Site Infection Risk: Intraoperative Surgical Infection Prevention and Wound Edge Contamination with guests Sue Barnes, RN, BSN, CIC, FAPIC and Jonathan Coe, President and CEO of Prescient Surgical.

Join us with guest Ron Romano, RN. Ron's background in healthcare and passion for Infection Prevention and Epidemiology is an asset to many. The main question in today's episode is not what products are being utilized to address germs and bacteria.

Power of Positive, a mindset that will take anyone from today forward. Listen to C.diff. Survivors as they share their journey.

Join us as our guests Dr. Mark Stine, DO, FACOI, and Celeste Wiggins, MBA, will discuss the state- of- the- art Footwear Sanitizing Station and New Technology Eliminating Pathogens. Patho3gen Solutions focus is on prevention, not treatment.

Join us with co Author, Jay Papasan of "The 1 Thing." Our guest will be discussing ways to move forward, personal growth, habits and reaching goals in life. If you have a questions for our guest, please e-mail it to info@cdifffoundation.

Join us with guests Dr. David Lyerly, PhD , PhD - Co-Founder, CSO of TechLab and James H. Boone, M.S.,Director of Collaborative Studies, Senior Research Scientist at TechLab. Both guests will be discussing C.diff. (C.

Join us with our guests, Katie Stewart, Director of Health Care Ratings and Lauren Bailey, Communications Manager Manager at The Leapfrog Group.

Join us with our guest Dr. Cliff Yahnke, Ph.D. as we discuss the problem - Current environmental disinfection methods are applied at discrete moments in time (ie.episodically).

Join our Guest Host, Kevin Hersh with guests Dr. Nam Tran (UC Davis), and Dr. Chris Newhouse (Roche) as they discuss the Role of Diagnostics In Supporting Antibiotic Stewardship Goals. Dr. Newhouse will be introducing Antibiotic Resistance with Dr.